FDA approves first fecal microbe therapy
ADC评论
December 2, 2022
On November 30, 2022, Ferring Pharmaceuticals announced that its microbiome therapy REBYOTA® (RBX2660) was approved by the FDA, becoming the first approved fecal microbial therapy.
